Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Sites/Blogs about Colombia
Educational Institutions


Crude Oil
US Gasoline Prices
Natural Gas

UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Cayman Islands

Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Costa Rica
El Salvador



What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines

  HOME | Business & Economy (Click here for more)

Purdue Pharma Files for Bankruptcy as per Settlement

NEW YORK – Pharmaceutical giant Purdue Pharma, the manufacturer of the highly addictive opioid OxyContin, has filed for bankruptcy in the United States to finalize and implement the agreement reached with some of its thousands of litigants, the firm said in a statement on Monday.

Now the focus of the case will move to discussions about how potential proceeds are to be divided among the communities whose residents have become addicted or died from overdoses of opioids produced by Purdue.

Although the settlement includes no admission of wrongdoing by the firm, it will result in Purdue’s reorganization into a trust that will continue to produce OxyContin, along with “rescue” drugs to be used if and when takers of the drug overdose on it. These rescue drugs will be distributed free of charge to communities around the US.

“We are hopeful of and expectant that a growing number of states will see this is a much better outcome for them than for us to go into the swamp of litigation that would basically eat up all the resources of the company,” Purdue Chairman Steve Miller told reporters in a Sunday night conference call.

The Sackler family, which owns Purdue, last week agreed to renounce their entire stake in the company to resolve the more than 2,600 lawsuits filed against it in courts around the country over its role in precipitating the nationwide opioid epidemic, and it said it would contribute $3 billion to the resolution of these cases.

Lawsuits have been filed against the firm in 24 states, five US territories and there is a multidistrict complaint outstanding against Purdue.

In its statement, Purdue said that the accord will provide “more than $10 billion” to alleviate the opioid crisis.

“This unique framework for a comprehensive resolution will dedicate all of the assets and resources of Purdue for the benefit of the American public,” Miller said in the firm’s statement.

“This settlement framework avoids wasting hundreds of millions of dollars and years on protracted litigation, and instead will provide billions of dollars and critical resources to communities across the country trying to cope with the opioid crisis,” he added.

Purdue said that the firm resulting from the renunciation of the Sackler family of its assets will be called NewCo, will be headed by a board approved by the bankruptcy court and will provide “tens of millions” of doses of rescue medications gratis to treat opioid overdoses.

However, according to The New York Times, it is expected that a group of states, including New York, that have opposed the agreement with Purdue and have sued the Sackler family, will reject this decision since it would permit the owners to continue participating in the industry via a subsidiary until they sell their business.


Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:


Copyright Latin American Herald Tribune - 2005-2020 © All rights reserved